Society of family planning clinical recommendations: contraceptive care in the context of pandemic response
BM Stifani, T Madden, E Micks, G Moayedi, J Tarleton… - Contraception, 2022 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has posed a burden to
healthcare systems around the world and has changed the way people access health …
healthcare systems around the world and has changed the way people access health …
Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years …
J Kountouras, D Gialamprinou, G Kotronis… - Medicina, 2022 - mdpi.com
The persistence of the coronavirus disease 2019 (COVID-19) pandemic has triggered
research into limiting transmission, morbidity and mortality, thus warranting a …
research into limiting transmission, morbidity and mortality, thus warranting a …
Achieving equity in postpartum contraception access
A McAllister, T Christensen, E Dixit… - Clinical Obstetrics …, 2023 - journals.lww.com
Equitable access to contraception and contraceptive education has the potential to mitigate
health disparities related to unintended pregnancy. Pregnancy and the postpartum window …
health disparities related to unintended pregnancy. Pregnancy and the postpartum window …
Service delivery at Title X sites in Texas during the COVID‐19 pandemic
Context The important role of Title X sites in supporting publicly funded reproductive
healthcare was elevated during the COVID‐19 pandemic, as many people experienced …
healthcare was elevated during the COVID‐19 pandemic, as many people experienced …
[HTML][HTML] Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States
AB Comfort, A Alvarez, S Goodman, U Upadhyay… - Contraception, 2024 - Elsevier
Objectives Depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) can be
prescribed through telemedicine and self-administered, but data about availability …
prescribed through telemedicine and self-administered, but data about availability …
Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19
TJ Smith, TK Urdanigo, N Shroff, SE Rubin - Contraception, 2023 - Elsevier
Objectives Self-administered subcutaneous (SC) depot medroxyprogesterone acetate
(DMPA) can improve contraception access by eliminating a health center visit for …
(DMPA) can improve contraception access by eliminating a health center visit for …
Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
A Alvarez, S Goodman, U Upadhyay, B Mengesha… - 2024 - escholarship.org
OBJECTIVES: Depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) can be
prescribed through telemedicine and self-administered, but data about availability …
prescribed through telemedicine and self-administered, but data about availability …
[PDF][PDF] 3. I am licensed to practice in the State of Pennsylvania. I am board certified in both Obstetrics and Gynecology and Complex Family Planning (American Board …
C SCHREIBER, AGOF WASHINGTON - affordablecareactlitigation.com
5. I currently serve on the editorial board of Contraception, and serve or have served as a
reviewer for Fertility and Sterility, Pharmacoepidemiology, and the American Journal of …
reviewer for Fertility and Sterility, Pharmacoepidemiology, and the American Journal of …